Healthtech Startups

Anatomiz3D develops patient-specific surgical planning solutions and tissue engineering products using 3D printing and bioprinting technologies for the healthcare industry. The company aims to improve surgical outcomes and eventually reduce organ transplant dependency through customized medical interventions.

1 investor

Anatoscope develops software that reconstructs and simulates a digital twin of a patient from data such as medical imaging or surface scans, working at the intersection of medical imaging and computer-aided design (CAD). Founded as a spin-off from Inria, CNRS, and the Grenoble-Alpes and Montpellier universities, it applies biomechanical simulation and digital design across medical fields via its subsidiaries.

1 investor

Anavex Life Sciences is a clinical-stage biopharmaceutical company developing oral therapeutics for central nervous system disorders, including Alzheimer's disease, Rett syndrome, and Fragile X syndrome. Its lead compound is ANAVEX 2-73 (blarcamesine), targeting early Alzheimer's and neurodevelopmental rare diseases.

1 investor

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.

1 investor

Anchor Health provides software, hardware, and operational systems for home health care agencies and distributed provider networks.

1 investor

Andor Health provides AI-powered virtual healthcare communication and collaboration solutions that enable real-time coordination between care teams to improve patient outcomes and reduce clinician burnout. The platform serves healthcare providers, hospitals, and health systems.

1 investor

Andson Biotech develops analytical tools for the analysis of biotherapeutics, aimed at supporting the discovery and development of biologic drugs.

1 investor

AndzonBio operates a suite of thematic "pipeline builder" studios that accelerate the industrial development of academic life sciences projects into biotech companies, focusing on specific therapeutic areas such as cardiovascular/renal/metabolic disorders and neurological disorders. Launched by AdBio Partners and Inserm Transfert, it provides expert support, R&D budgets, and validation to turn academic programs into viable therapeutics companies.

1 investor

Andzonbio1 is a biotech start-up developing therapeutics and building a pipeline, supported by public and private funding sources in France. The company is backed by Inserm Transfert and AdBio partners, both focused on life sciences innovation and early-stage therapeutic investments.

1 investor

AndzonBio2 develops neuroinflammation therapies targeting STING and lipid peroxidation pathways, aiming to intervene in central nervous system diseases through translational research and drug development.

1 investor

Anebulo Pharmaceuticals is developing selonabant, a drug candidate intended to reverse cannabis-induced toxicities, including acute CNS depression in children and acute cannabinoid intoxication in adults. The company is a clinical-stage pharmaceutical developer targeting conditions for which there are no approved treatments.

1 investor

AnewHealth provides comprehensive pharmacy services for people with chronic conditions and complex medical needs, helping optimize medication therapies and reduce healthcare costs. The company supports home- and community-based care through its ExactCare platform and advocates for policy changes to expand access to quality long-term care pharmacy services.

1 investor

Angel MedFlight provides air ambulance and medical transportation services for patients requiring long-distance transfers, equipped with intensive care capabilities and staffed with critical care medical professionals. The company serves patients needing trauma care, specialty treatment, rehabilitation, and international medical repatriation across state and country borders.

1 investor

AngelEye Health provides an integrated AI-driven platform for neonatal and pediatric care teams at hospitals, combining video monitoring, feeding management, patient education, and discharge coordination. The platform connects caregivers and families through secure connections, improving clinical outcomes and operational efficiency for pediatric patients.

1 investor

AngelSense provides a personal GPS tracking and monitoring service designed for the special needs community, helping parents and caregivers locate and safeguard children with special needs. Its customer care team is staffed by special needs parents who use the product with their own children.

1 investor

AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations. The company operates in the biotech and cancer therapeutics space, using tumor sequencing to identify neoantigens and manufacture DC and T-cell products.

1 investor

AngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.

1 investor

AngioInsight develops AI-driven diagnostic tools for earlier and more precise identification and management of coronary artery disease, serving clinicians and patients in cardiovascular healthcare.

1 investor

AniCura operates a network of nearly 500 veterinary clinics across 15 European countries, providing preventive, basic, and specialized animal healthcare including diagnostics, surgery, orthopaedics, rehabilitation, and dietary advice. It serves pet owners and treats over 4.5 million pets annually, and has been part of Mars Veterinary Health since 2018.

1 investor

Animal Health Partners Toronto operates an emergency and specialty veterinary hospital providing specialized animal healthcare services. The facility combines advanced veterinary medicine practices with emergency care for companion animals.

1 investor

Anjo is an AI platform that uses data from smart wearables to continuously monitor physiological signals and detect early signs of allergic reactions or anaphylaxis. It provides remote monitoring, alerts, and allergy insights for families and individuals living with life-threatening allergies, and supplies data to physicians for care decisions.

1 investor

Anju Software provides data management and integration solutions for pharmaceutical companies, clinical research organizations, and medical device companies. The company specializes in life science information management systems that enable data flow and third-party system connectivity.

1 investor

A German medical supply store (Sanitätshaus) offering health and orthopedic products along with individual advice and custom-fitted solutions for consumers. It focuses on aids intended to support daily life and health.

1 investor

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

1 investor